HIF-1α signaling by airway epithelial cell K-α1-tubulin: Role in fibrosis and chronic rejection of human lung allografts

Cellular Immunology

Volumn 273, Issue 1, 2012, Pages 59-66

  Tiriveedhi, Venkataswarup ^a   Gelman, Andrew E ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody; Autoimmunity; Bronchiolitis obliterans syndrome; Chronic rejection; Fibrosis; Growth factors; Hypoxia inducible factor; Lung transplant; Self antigen; Signaling

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; K ALPHA 1 TUBULIN; STRESS ACTIVATED PROTEIN KINASE; TUBULIN; UNCLASSIFIED DRUG;

ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHUS MUCOSA; CHRONIC GRAFT REJECTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME INHIBITION; EPITHELIUM CELL; FIBRIN FORMATION; HUMAN; HUMAN CELL; LUNG FIBROSIS; LUNG GRAFT REJECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; BRONCHIOLITIS OBLITERANS; CELL LINE; CONNEXINS; EPITHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; GRAFT REJECTION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG TRANSPLANTATION; PLATELET-DERIVED GROWTH FACTOR; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84856012371     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.11.006     Document Type: Article

References (49)

1. Christie J.D., Edwards L.B., Aurora P., Dobbels F., Kirk R., Rahmel A.O., Taylor D.O., Kucheryavaya A.Y., Hertz M.I. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report-2008. J Heart Lung Transplant 2008, 27:957-969.
2. Jaramillo A., Naziruddin B., Zhang L., Reznik S.I., Smith M.A., Aloush A.A., Trulock E.P., Patterson G.A., Mohanakumar T. Activation of human airway epithelial cells by non-HLA antibodies developed after lung transplantation: a potential etiological factor for bronchiolitis obliterans syndrome. Transplantation 2001, 71:966-976.
3. Dragun D., Muller D.N., Brasen J.H., Fritsche L., Nieminen-Kelha M., Dechend R., Kintscher U., Rudolph B., Hoebeke J., Eckert D., Mazak I., Plehm R., Schonemann C., Unger T., Budde K., Neumayer H.H., Luft F.C., Wallukat G. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005, 352:558-569.
4. Dubel L., Farges O., Johanet C., Sebagh M., Bismuth H. High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation 1998, 65:1072-1075.
5. Zissel G., Ernst M., Rabe K., Papadopoulos T., Magnussen H., Schlaak M., Muller-Quernheim J. Human alveolar epithelial cells type II are capable of regulating T-cell activity. J Investig Med 2000, 48:66-75.
6. Mauck K.A., Hosenpud J.D. The bronchial epithelium: a potential allogeneic target for chronic rejection after lung transplantation. J Heart Lung Transplant 1996, 15:709-714.
7. Thompson A.B., Robbins R.A., Romberger D.J., Sisson J.H., Spurzem J.R., Teschler H., Rennard S.I. Immunological functions of the pulmonary epithelium. Eur Respir J 1995, 8:127-149.
8. O'Brien A.D., Standiford T.J., Christensen P.J., Wilcoxen S.E., Paine R. Chemotaxis of alveolar macrophages in response to signals derived from alveolar epithelial cells. J Lab Clin Med 1998, 131:417-424.
9. Desai T.J., Cardoso W.V. Growth factors in lung development and disease: friends or foe?. Respir Res 2002, 3:2.
10. Bergmann M., Tiroke A., Schafer H., Barth J., Haverich A. Gene expression of profibrotic mediators in bronchiolitis obliterans syndrome after lung transplantation. Scand Cardiovasc J 1998, 32:97-103.
11. Huang L.E., Bunn H.F. Hypoxia-inducible factor and its biomedical relevance. J Biol Chem 2003, 278:19575-19578.
12. Bos R., van Diest P.J., de Jong J.S., van der Groep P., van der Valk P., van der Wall E. Hypoxia-inducible factor-1alpha is associated with angiogenesis and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 2005, 46:31-36.
13. Chun Y.S., Yeo E.J., Choi E., Teng C.M., Bae J.M., Kim M.S., Park J.W. Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells. Biochem Pharmacol 2001, 61:947-954.
14. Tzouvelekis A., Harokopos V., Paparountas T., Oikonomou N., Chatziioannou A., Vilaras G., Tsiambas E., Karameris A., Bouros D., Aidinis V. Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis. Am J Respir Crit Care Med 2007, 176:1108-1119.
15. Jiang X., Khan M.A., Tian W., Beilke J., Natarajan R., Kosek J., Yoder M.C., Semenza G.L., Nicolls M.R. Adenovirus-mediated HIF-1alpha gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection. J Clin Invest 2011, 121:2336-2349.
16. Goers T.A., Ramachandran S., Aloush A., Trulock E., Patterson G.A., Mohanakumar T. De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol 2008, 180:4487-4494.
17. Tiriveedhi V., Angaswamy N., Weber J., Mohanakumar T. Lipid raft facilitated ligation of K-alpha1-tubulin by specific antibodies on epithelial cells: Role in pathogenesis of chronic rejection following human lung transplantation. Biochem Biophys Res Commun 2010, 399:251-255.
18. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000, 351:95-105.
19. L. Li, Y. Lu, Inhibition of Hypoxia-Induced Cell Motility by p16 in MDA-MB-231 Breast Cancer Cells, J Cancer 1 126-135.
20. A.J. Leger, A. Altobelli, L.M. Mosquea, A.J. Belanger, A. Song, S.H. Cheng, C. JiangN.S. Yew, Inhibition of osteoclastogenesis by prolyl hydroxylase inhibitor dimethyloxallyl glycine, J Bone Miner Metab 28 510-519.
21. Tracy K., Dibling B.C., Spike B.T., Knabb J.R., Schumacker P., Macleod K.F. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol 2007, 27:6229-6242.
22. Walker C., Bettens F., Pichler W.J. T cell activation by cross-linking anti-CD3 antibodies with second anti-T cell antibodies: dual antibody cross-linking mimics physical monocyte interaction. Eur J Immunol 1987, 17:1611-1618.
23. Tsubata T., Wu J., Honjo T. B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 1993, 364:645-648.
24. Boesiger J., Tsai M., Maurer M., Yamaguchi M., Brown L.F., Claffey K.P., Dvorak H.F., Galli S.J. Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med 1998, 188:1135-1145.
25. Dykstra M., Cherukuri A., Pierce S.K. Rafts and synapses in the spatial organization of immune cell signaling receptors. J Leukoc Biol 2001, 70:699-707.
26. Bridle K.R., Popa C., Morgan M.L., Sobbe A.L., Clouston A.D., Fletcher L.M., Crawford D.H. Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways. Liver Transpl 2009, 15:1315-1324.
27. Y. Lu, N. Azad, L. Wang, A.K. Iyer, V. Castranova, B.H. JiangY. Rojanasakul, Phosphatidylinositol-3-kinase/akt regulates bleomycin-induced fibroblast proliferation and collagen production, Am J Respir Cell Mol Biol 42 432-441.
28. Higgins D.F., Kimura K., Bernhardt W.M., Shrimanker N., Akai Y., Hohenstein B., Saito Y., Johnson R.S., Kretzler M., Cohen C.D., Eckardt K.U., Iwano M., Haase V.H. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007, 117:3810-3820.
29. Shi Y.H., Bingle L., Gong L.H., Wang Y.X., Corke K.P., Fang W.G. Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells. Pathology 2007, 39:396-400.
30. Sheta E.A., Trout H., Gildea J.J., Harding M.A., Theodorescu D. Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathways. Oncogene 2001, 20:7624-7634.
31. Yeo E.J., Chun Y.S., Cho Y.S., Kim J., Lee J.C., Kim M.S., Park J.W. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst 2003, 95:516-525.
32. Sun H.L., Liu Y.N., Huang Y.T., Pan S.L., Huang D.Y., Guh J.H., Lee F.Y., Kuo S.C., Teng C.M. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Oncogene 2007, 26:3941-3951.
33. Kim H.L., Yeo E.J., Chun Y.S., Park J.W. A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent. Int J Oncol 2006, 29:255-260.
34. Serra-Perez A., Planas A.M., Nunez-O'Mara A., Berra E., Garcia-Villoria J., Ribes A., Santalucia T. Extended ischemia prevents HIF1alpha degradation at reoxygenation by impairing prolyl-hydroxylation: role of Krebs cycle metabolites. J Biol Chem 1821, 285:7-18224.
35. Zheng X., Ruas J.L., Cao R., Salomons F.A., Cao Y., Poellinger L., Pereira T. Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization. Mol Cell Biol 2006, 26:4628-4641.
36. Cummins E.P., Berra E., Comerford K.M., Ginouves A., Fitzgerald K.T., Seeballuck F., Godson C., Nielsen J.E., Moynagh P., Pouyssegur J., Taylor C.T. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A 2006, 103:18154-18159.
37. Alcaide-German M.L., Vara-Vega A., Garcia-Fernandez L.F., Landazuri M.O., Del Peso L. A yeast three-hybrid system that reconstitutes mammalian hypoxia inducible factor regulatory machinery. BMC Cell Biol 2008, 9:18.
38. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., Kriegsheim A., Hebestreit H.F., Mukherji M., Schofield C.J., Maxwell P.H., Pugh C.W., Ratcliffe P.J. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001, 292:468-472.
39. Saklatvala J., Rawlinson L., Waller R.J., Sarsfield S., Lee J.C., Morton L.F., Barnes M.J., Farndale R.W. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem 1996, 271:6586-6589.
40. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995, 364:229-233.
41. Knight D.A., Holgate S.T. The airway epithelium: structural and functional properties in health and disease. Respirology 2003, 8:432-446.
42. Holgate S.T. Epithelial damage and response. Clin Exp Allergy 2000, 30:37-41. Suppl 1.
43. Kimura K., Iwano M., Higgins D.F., Yamaguchi Y., Nakatani K., Harada K., Kubo A., Akai Y., Rankin E.B., Neilson E.G., Haase V.H., Saito Y. Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 2008, 295:F1023-F1029.
44. DeNiro M., Alsmadi O., Al-Mohanna F. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis. Exp Eye Res 2009, 89:700-717.
45. Moon J.O., Welch T.P., Gonzalez F.J., Copple B.L. Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice. Am J Physiol Gastrointest Liver Physiol 2009, 296:G582-592.
46. Halberg N., Khan T., Trujillo M.E., Wernstedt-Asterholm I., Attie A.D., Sherwani S., Wang Z.V., Landskroner-Eiger S., Dineen S., Magalang U.J., Brekken R.A., Scherer P.E. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 2009, 29:4467-4483.
47. Peyssonnaux C., Cejudo-Martin P., Doedens A., Zinkernagel A.S., Johnson R.S., Nizet V. Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol 2007, 178:7516-7519.
48. Ben-Shoshan J., Maysel-Auslender S., Mor A., Keren G., George J. Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha. Eur J Immunol 2008, 38:2412-2418.
49. Yasui H., Ogura A., Asanuma T., Matsuda A., Kashiwakura I., Kuwabara M., Inanami O. Inhibition of HIF-1alpha by the anticancer drug TAS106 enhances X-ray-induced apoptosis in vitro and in vivo. Br J Cancer 2008, 99:1442-1452.